More on cetuximab in head and neck cancer

N Engl J Med. 2007 Nov 22;357(21):2201-2; author reply 2202-3. doi: 10.1056/NEJMc071540.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / radiotherapy
  • Cetuximab
  • Combined Modality Therapy
  • Disease-Free Survival
  • ErbB Receptors / immunology*
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Kaplan-Meier Estimate
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Cetuximab